跳至主要内容
临床试验/NL-OMON28055
NL-OMON28055招募中不适用

ew strategies to detect cancers in carriers of mutations in RB1: blood tests based on tumor-educated platelets, or extracellular vesicles.

one0 个研究点目标入组 396 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
one
入组人数
396

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • o Group 1: germline mutation RB1.
  • o Group 2 (control): no germline mutation RB1.
  • - Pediatric:
  • o Group 1: somatic or germline mutation RB1
  • o Group 2 (control): no mutation RB1.

排除标准

  • o Group 1: concomitant heritable (inherited) disorder other than caused by monoalleic mutation of RB1.
  • o Group 2 (control): cancer or already known cancer predisposition syndrome.
  • - Pediatric:
  • o Group 1: concomitant heritable (inherited) disorder other than caused by monoalleic mutation of RB1.
  • o Group 2: cancer or already known cancer predisposition syndrome.

研究者

发起方
one

相似试验